Literature DB >> 24397987

Gene silencing in human aortic smooth muscle cells induced by PEI-siRNA complexes released from dip-coated electrospun poly(ethylene terephthalate) grafts.

Christoph S Nabzdyk1, Maggie C Chun2, Hunter S Oliver-Allen2, Saif G Pathan3, Matthew D Phaneuf3, Jin-Oh You4, Leena K Pradhan-Nabzdyk5, Frank W LoGerfo6.   

Abstract

An excessive tissue response to prosthetic arterial graft material leads to intimal hyperplasia (IH), the leading cause of pan> class="Disease">late graft failure. Seroma and abnormal capsule formation may also occur after prosthetic material implantation. The matricellular protein Thrombospondin-2 (TSP-2) has shown to be upregulated in response to biomaterial implantation. This study evaluates the uptake and release of small interfering RNA (siRNA) from unmodified and surface functionalized electrospun PET graft materials. ePET graft materials were synthesized using electrospinning technology. Subsets of the ePET materials were then chemically modified to create surface functional groups. Unmodified and surface-modified ePET grafts were dip-coated in siRNAs alone or siRNAs complexed with transfection reagents polyethyleneimine (PEI) or Lipofectamine RNAiMax. Further, control and TSP-2 siRNA-PEI complex treated ePET samples were placed onto a confluent layer of human aortic smooth muscle cells (AoSMCs). Complexation of all siRNAs with PEI led to a significant increase in adsorption to unmodified ePET. TSP-2 siRNA-PEI released from unmodified-ePET silenced TSP-2 in AoSMC. Regardless of the siRNA-PEI complex evaluated, AoSMC migrated into the ePET. siRNA-PEI complexes delivered to AoSMC from dip-coated ePET can result in gene knockdown. This methodology for siRNA delivery may improve the tissue response to vascular and other prosthetics.
Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Human aortic smooth muscle cells; Polyester; Silencing RNA; Thrombospondin-2; Transfection reagents

Mesh:

Substances:

Year:  2014        PMID: 24397987      PMCID: PMC3929209          DOI: 10.1016/j.biomaterials.2013.12.026

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  37 in total

1.  Clinical evaluation of dacron suture material.

Authors:  B H SHUMACKER; I MANDELBAUM
Journal:  Arch Surg       Date:  1961-11

2.  Clinical experience with dacron as a nonabsorbable suture material.

Authors:  E O LATIMER; J A WERR
Journal:  Surg Gynecol Obstet       Date:  1961-03

3.  Evaluation of dacron suture material for general surgery.

Authors:  J K NARAT; J P CANGELOSI; J V BELMONTE
Journal:  Surg Forum       Date:  1957

4.  Mice that lack the angiogenesis inhibitor, thrombospondin 2, mount an altered foreign body reaction characterized by increased vascularity.

Authors:  T R Kyriakides; K J Leach; A S Hoffman; B D Ratner; P Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

5.  Trapezium resection with mersilene suspension sling.

Authors:  Marwan A Wehbé; Rita M Ciccarello; Jennifer L Reitz
Journal:  Hand Clin       Date:  2013-02       Impact factor: 1.907

Review 6.  Polyethylenimine as a promising vector for targeted siRNA delivery.

Authors:  Surendra Nimesh
Journal:  Curr Clin Pharmacol       Date:  2012-05

7.  Prosthetic incisional hernioplasty: clinical experience with 354 cases.

Authors:  A Abdollahi; G H Maddah; B M Mehrabi; A Jangjoo; M N Forghani; N Sharbaf
Journal:  Hernia       Date:  2010-08-09       Impact factor: 4.739

8.  Modification of polyethylene terephthalate (Dacron) via denier reduction: effects on material tensile strength, weight, and protein binding capabilities.

Authors:  M D Phaneuf; W C Quist; M J Bide; F W LoGerfo
Journal:  J Appl Biomater       Date:  1995

9.  Management of voluminous abdominal incisional hernia.

Authors:  J-L Bouillot; T Poghosyan; T Pogoshian; N Corigliano; G Canard; N Veyrie
Journal:  J Visc Surg       Date:  2012-11-06       Impact factor: 2.043

10.  ADAMTS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries.

Authors:  Li Wang; Jingang Zheng; Xue Bai; Bo Liu; Chuan-Ju Liu; Qingbo Xu; Yi Zhu; Nanping Wang; Wei Kong; Xian Wang
Journal:  Circ Res       Date:  2009-01-22       Impact factor: 17.367

View more
  10 in total

Review 1.  Technologies for controlled, local delivery of siRNA.

Authors:  Samantha M Sarett; Christopher E Nelson; Craig L Duvall
Journal:  J Control Release       Date:  2015-11-28       Impact factor: 9.776

Review 2.  Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization.

Authors:  Andrew J Sawyer; Themis R Kyriakides
Journal:  Adv Drug Deliv Rev       Date:  2016-01-04       Impact factor: 15.470

Review 3.  Electrospun-Fibrous-Architecture-Mediated Non-Viral Gene Therapy Drug Delivery in Regenerative Medicine.

Authors:  Elena Cojocaru; Jana Ghitman; Raluca Stan
Journal:  Polymers (Basel)       Date:  2022-06-29       Impact factor: 4.967

Review 4.  Current siRNA targets in atherosclerosis and aortic aneurysm.

Authors:  Leena Pradhan-Nabzdyk; Chenyu Huang; Frank W LoGerfo; Christoph S Nabzdyk
Journal:  Discov Med       Date:  2014-05       Impact factor: 2.970

Review 5.  Current siRNA targets in the prevention and treatment of intimal hyperplasia.

Authors:  Leena Pradhan-Nabzdyk; Chenyu Huang; Frank W LoGerfo; Christoph S Nabzdyk
Journal:  Discov Med       Date:  2014-09       Impact factor: 2.970

Review 6.  Electrospun nanofibers as versatile interfaces for efficient gene delivery.

Authors:  Slgirim Lee; Gyuhyung Jin; Jae-Hyung Jang
Journal:  J Biol Eng       Date:  2014-12-09       Impact factor: 4.355

7.  The effects of transfection reagent polyethyleneimine (PEI) and non-targeting control siRNAs on global gene expression in human aortic smooth muscle cells.

Authors:  Nurazhani A Raof; Deepa Rajamani; Hsun-Chieh Chu; Aniket Gurav; Joel M Johnson; Frank W LoGerfo; Leena Pradhan-Nabzdyk; Manoj Bhasin
Journal:  BMC Genomics       Date:  2016-01-05       Impact factor: 3.969

Review 8.  RNAi therapy to the wall of arteries and veins: anatomical, physiologic, and pharmacological considerations.

Authors:  Christoph S Nabzdyk; Leena Pradhan-Nabzdyk; Frank W LoGerfo
Journal:  J Transl Med       Date:  2017-07-28       Impact factor: 5.531

9.  Gene Silencing via PDA/ERK2-siRNA-Mediated Electrospun Fibers for Peritendinous Antiadhesion.

Authors:  Shen Liu; Fei Wu; Shanshan Gu; Tianyi Wu; Shun Chen; Shuai Chen; Chongyang Wang; Guanlan Huang; Tuo Jin; Wenguo Cui; Bruno Sarmento; Lianfu Deng; Cunyi Fan
Journal:  Adv Sci (Weinh)       Date:  2018-11-20       Impact factor: 16.806

10.  Delivery of targeted gene therapies using a hybrid cryogel-coated prosthetic vascular graft.

Authors:  Frank LoGerfo; Leena Pradhan-Nabzdyk; Cindy Huynh; Ting-Yu Shih; Alexander Mammoo; Amruta Samant; Saif Pathan; David W Nelson; Christiane Ferran; David Mooney
Journal:  PeerJ       Date:  2019-08-20       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.